This study deciphered the BRCA1/2 variant profile, including LGR, in a large population of 56126 pan-cancer patients from the Chinese mainland; the largest Chinese cohort analyzed using NGS for BRCA1/2 LGR cancers to date. This evidence concerns the gene BRCA1 and cancer.